Fig. 2From: Changes in plasma EBV-DNA and immune status in patients with nasopharyngeal carcinoma after treatment with intensity-modulated radiotherapyPre- and post-radiotherapy findings of patients compared with healthy donors (*P < 0.05, **P < 0.01, ***P < 0.001). Abbreviations: HD, healthy donors; L, absolute lymphocyte count; N, absolute neutrophil count; NLR, neutrophil–lymphocyte ratio Pre, pre-radiotherapy; Post, post-radiotherapy; Treg, CD4+CD25+CD127lowBack to article page